GC Biopharma, a South Korean biopharmaceutical company, announced on Feb. 10th that it presented development updates on its LSD (lysosomal storage disorder) pipelines at the WORLD Symposium 2025, held ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback